These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7556709)

  • 21. The mechanisms of corneal graft failure in the rat.
    Katami M
    Eye (Lond); 1995; 9 ( Pt 2)():197-207. PubMed ID: 7556718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WOFIE hypothesis: some thoughts on an approach toward allograft tolerance.
    Calne R
    Transplant Proc; 1996 Jun; 28(3):1152. PubMed ID: 8658605
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase.
    Lan Z; Ge W; Arp J; Jiang J; Liu W; Gordon D; Healey D; DeBenedette M; Nicolette C; Garcia B; Wang H
    Transplantation; 2010 Dec; 90(12):1286-93. PubMed ID: 21076370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.
    Benichou G; Tam RC; Soares LR; Popov IA; Garovoy MR; Fedoseyeva EV
    Res Immunol; 1996; 147(6):377-87. PubMed ID: 8903104
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell tolerance.
    Strober S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):34-5. PubMed ID: 1990549
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of dendritic cells and T cell activation in allograft rejection.
    Roake JA; Austyn JM
    Exp Nephrol; 1993; 1(2):90-101. PubMed ID: 8081962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.
    Adorini L; Penna G; Giarratana N; Uskokovic M
    J Cell Biochem; 2003 Feb; 88(2):227-33. PubMed ID: 12520519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.
    Huang Y; Chen P; Zhang CB; Ko GJ; Ruiz M; Fiorina P; Hussain MA; Wasowska BA; Rabb H; Womer KL
    Transplantation; 2010 Dec; 90(12):1307-11. PubMed ID: 21048532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between changes in cellular immunity and rejection in rat small bowel transplantation.
    Wang P; Zhu L; Liu T; He X; Zhu W
    Transplant Proc; 1994 Jun; 26(3):1557. PubMed ID: 7913267
    [No Abstract]   [Full Text] [Related]  

  • 31. Another dendritic cell enters the transplant story.
    Perkins JD
    Liver Transpl; 2006 Aug; 12(8):1296-7. PubMed ID: 16948184
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of corneal endothelial destruction in rejecting rat corneal allografts and xenografts: a role for CD4+ cells.
    Takano T; Williams KA
    Transplant Proc; 1995 Feb; 27(1):260-1. PubMed ID: 7878994
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of allograft rejection].
    Lantz O; Alard P; Charpentier B
    Pathol Biol (Paris); 1993 Jun; 41(6):515-20. PubMed ID: 8247629
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased IFN-gamma and IL-2 mRNA expression in peripheral tolerance to heart allografts with conserved granzyme A, perforin, and MHC antigens mRNA expression.
    Bugeon L; Cuturi MC; Paineau J; Chabannes D; Soulillou JP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):314-6. PubMed ID: 8438315
    [No Abstract]   [Full Text] [Related]  

  • 36. Unique aspects of rejection and tolerance in liver transplantation.
    Knechtle SJ; Kwun J
    Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of prolongation of graft survival.
    Carpenter CB
    Transplant Proc; 1979 Dec; 11(4):1885-8. PubMed ID: 161100
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte infiltration and Ia expression in liver allografts in rats.
    Kubota N; Monden M; Hasuike Y; Valdivia LA; Gotoh M; Mori T; Onoue K; Wakasa K; Sakurai M
    Transplant Proc; 1988 Apr; 20(2):214-6. PubMed ID: 3284044
    [No Abstract]   [Full Text] [Related]  

  • 39. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences.
    Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH
    Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.